Aubert, Martine http://orcid.org/0000-0003-1125-6856
Haick, Anoria K.
Strongin, Daniel E.
Klouser, Lindsay M. http://orcid.org/0000-0002-9644-361X
Loprieno, Michelle A. http://orcid.org/0000-0002-2905-485X
Stensland, Laurence
Santo, Tracy K.
Huang, Meei-Li
Hyrien, Ollivier
Stone, Daniel http://orcid.org/0000-0003-1619-7541
Jerome, Keith R. http://orcid.org/0000-0002-8212-3789
Article History
Received: 22 January 2023
Accepted: 15 April 2024
First Online: 13 May 2024
Competing interests
: K.R.J. is a founder and holds equity in Caladan Therapeutics, is a paid advisor and holds equity in Excision Biosciences, participates in sponsored research agreements with Excision Biosciences and Emendo Biotherapeutics, and is co-inventor of International Patent Application No. PCT/US2022/013757 and U.S. Provisional Application No. 63/503,541 held by Fred Hutch for the treatment of HSV-1 and HSV-2 using meganucleases. There are no restrictions on publication of data. M.A. and D.S. have sponsored research agreements with Excision Biosciences. The remaining authors declare no conflict of interest.